Evidence map›Paper›PMID 30531811›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2019

Secondary research uses of residual newborn screening dried bloodspots: a scoping review.

Erin Rothwell, Erin Johnson, Naomi Riches, Jeffrey R Botkin

Abstract readScoping Review
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Determinants of maternal and neonatal PFAS concentrations: a review.Environmental health : a global access science source · 2023
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Erin RothwellSchool of Medicine, Department of Ob/Gyn and Pediatrics, University of Utah, Salt Lake City, UT, USA. erin.rothwell@hsc.utah.edu.
Erin JohnsonSchool of Medicine, Department of Ob/Gyn and Pediatrics, University of Utah, Salt Lake City, UT, USA.
Naomi RichesSchool of Medicine, Department of Ob/Gyn and Pediatrics, University of Utah, Salt Lake City, UT, USA.
Jeffrey R BotkinSchool of Medicine, Department of Ob/Gyn and Pediatrics, University of Utah, Salt Lake City, UT, USA.

Funding

Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
University of Utah Center for Clinical and Translational ScienceUL1TR001067 · NCATS · UNIVERSITY OF UTAH · PI DERE, WILLARD H., HESS, RACHEL · 2013 to 2017
$19.8M
Utah Center of Excellence in ELSI Research: UCEERRM1HG009037 · NHGRI · UNIVERSITY OF UTAH · PI ROTHWELL, ERIN, TABERY, JAMES · 2016 to 2024
$8.0M
The Effect of Electronic Informed Consent Information (EICI) on Residual Newborn Specimen ResearchR01HD082148 · NICHD · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Aaron J Goldenberg, ERIN ROTHWELL · 2015 to 2026
$5.1M
NCATS NIH HHS UL1 TR001067NCATS NIH HHS UL1 TR002538NHGRI NIH HHS RM1 HG009037NICHD NIH HHS R01 HD082148
6 · The paper itself

Abstract

purposeResidual newborn screening dried bloodspots (DBS) are a valuable resource for research but the extent, type, and nature of uses are unknown. The objective of this research was to systematically review the published literature about secondary research uses of residual DBS using a scoping review protocol.

methodsA total of 654 publications meeting the inclusion criteria with a 94% interrater reliability were identified. A coding template was created with input from expert advisory board to summarize the data. Electronic literature search of Ovid MEDLINE, Embase (via Embase.com), CINAHL (EBSCO),and Science and Social Sciences Citation Indices (via Web of Science) was conducted.

resultsA large proportion of the secondary research with DBS was conducted within the United States (30%). The number of published studies utilizing DBS are increasing each year, primarily with observational or case-control designs. Only a small number of studies reported whether or not consent was obtained and if the DBS were identifiable or not.

conclusionOutcomes of this research indicate that residual DBS are well utilized worldwide for research addressing individual and public health issues. Future analyses will summarize outcomes of disease-specific research and provide evidence of the use of residual DBS in research on health outcomes.

Indexed as

Biomedical ResearchDried Blood Spot TestingHumansInfant, NewbornReproducibility of Resultsdried bloodspotsevidence synthesisnewborn screeningscoping review

Identifiers

PMID30531811
PMCPMC6557682

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.